Request Deal Involvement

SV Health Investors, Sanofi Ventures, Abingworth, and SymBiosis led a $112m Series C round in AdvanCell.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Principals

SYMBIOSIS

bidder

SYMBIOSIS

SANOFI VENTURES

bidder

SANOFI VENTURES

BRANDON CAPITAL

bidder

BRANDON CAPITAL

ADVANCELL

target

ADVANCELL

SV HEALTH INVESTORS

bidder

SV HEALTH INVESTORS

ABINGWORTH MANAGEMENT

bidder

ABINGWORTH MANAGEMENT

MORNINGSIDE VENTURE CAPITAL

bidder

MORNINGSIDE VENTURE CAPITAL

TENMILE

bidder

TENMILE

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite